Interleukin-36 Receptor Antagonist Protein (IL36RN) Antibody

Este producto es parte de IL36RN - Interleukin-36 receptor antagonist protein
Product Graph
273€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Interleukin-36 Receptor Antagonist Protein (IL36RN) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx129639
tested applications
IHC

Description

Interleukin-36 Receptor Antagonist Protein (IL36RN) Antibody is a Rabbit Polyclonal against Interleukin-36 Receptor Antagonist Protein (IL36RN).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: Interleukin-36 Receptor Antagonist Protein (IL36RN)
Immunogen: FIL1d (Met1-Asp156)
Host
Rabbit
Reactivity
Mouse
Recommended Dilution
WB (Predicted): 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC (Predicted): 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1
100 µl
Size 2
200 µl
Size 3
1 ml
Form
Liquid
Tested Applications
IHC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9QYY1
Alias
IL-36Ra,IL-1F5,FIL1, FIL1Delta,IL1F5
Background
Antibody anti-IL36RN
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

IL36RN, also known as IL-36Ra, is an anti-inflammatory cytokine that functions as a natural inhibitor of IL-36 signaling. It binds to the IL-36 receptor (IL1RL2) and prevents its activation by IL36A, IL36B, and IL36G, thereby blocking downstream NF-κB, MAPK, and JNK signaling pathways. IL36RN is primarily expressed in keratinocytes, epithelial cells, and immune cells, where it regulates inflammation and prevents excessive immune activation at epithelial barriers. It plays a key role in maintaining tissue homeostasis and limiting pathological inflammation in conditions such as psoriasis, where mutations in IL36RN lead to uncontrolled IL-36 activity, severe inflammation, and pustular psoriasis. IL36RN is also implicated in mucosal immunity and inflammatory diseases of the skin, lungs, and gastrointestinal tract. Knockout studies reveal heightened IL-36 signaling, excessive cytokine production, and severe tissue inflammation, underscoring IL36RN's role as a key anti-inflammatory regulator and protective factor in immune homeostasis and barrier tissue health.

Related Products

EH5010

Human IL36RN (Interleukin-36 receptor antagonist protein) ELISA Kit

Ver Producto
FNab04238

IL36RN antibody

Ver Producto
P1161

Recombinant Mouse IL36RN

Ver Producto